ArticleMolecular psychiatry2026
Peripheral immune-redox signatures associate with cortical network alterations in anhedonic depression.
Article in Molecular psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Anhedonia is a core feature of major depressive disorder (MDD), yet links between peripheral molecular signatures and cortical network architecture remain poorly defined. We enrolled 210 participants, including 56 unmedicated MDD patients with high-anhedonia (HA), 61 with low-anhedonia (LA), and 93 healthy controls (HC). Morphometric similarity networks (MSNs) from structural MRI were compared between HA and LA. MSNs index individual-level network organization by quantifying inter-regional morphometric similarity. Regional MSN patterns were linked to Allen Human Brain Atlas using Spearman correlations with spin tests and a multi-K stability screen. Whole-blood RNA-seq (n = 199) was integrated with MSN features via sparse partial least squares-canonical correlation (sPLS-C), with key blood analyses repeated after leukocyte-composition adjustment. Gene Ontology over-representation and MAGMA gene-level analyses provided pathway context. HA showed greater MSN integration than LA, particularly within default-mode and somatomotor networks. MSN maps were negatively correlated with dopamine-transporter and kappa-opioid-receptor densities. Imaging-derived gene associations were enriched for regulation of Toll-like-receptor-3 signaling. In blood, sPLS-C revealed coupling between MSN features and a transcriptomic signature enriched for T-cell activation/differentiation and lymphocyte-apoptosis pathways. After composition adjustment, the pre-specified blood signature did not differ between HA and LA, indicating that between-group differences were largely composition-driven. As supportive genetic context, over-representation on MAGMA FDR-significant genes suggested protocadherin-mediated homophilic adhesion. Peripheral immune-redox pathway enrichment aligns with anhedonia-related cortical network alterations, whereas between-group blood differences are chiefly composition-driven. Adjusting for blood-cell composition is essential, this multimodal framework nominates immune-modulatory/redox targets and synaptic-adhesion biology for precision stratification and intervention.
Indexed as
Identifiers
41862569What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.